Skip to main content
John Winkelman, MD, Psychiatry, Boston, MA

John W. Winkelman MD

Sleep Medicine


Associate Professor in Psychiatry at Harvard Medical School and chief of the Sleep Disorders Clinical Research Program in the Department of Psychiatry at Massachusetts General Hospital

Join to View Full Profile
  • 55 Fruit StBoston, MA 02114

  • Phone+1 617-724-7426

Dr. Winkelman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Massachusetts General Hospital/McLean Hospital
    Mass General Brigham/Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1988 - 1991
  • University of California (San Francisco)/Mount Zion
    University of California (San Francisco)/Mount ZionInternship, Internal Medicine, 1987 - 1988
  • Harvard Medical School
    Harvard Medical SchoolClass of 1987

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1993 - 2027
  • MA State Medical License
    MA State Medical License 1991 - 2026
  • ME State Medical License
    ME State Medical License 2021 - 2026
  • Psychiatry
    American Board of Psychiatry and Neurology Psychiatry
  • Sleep Medicine
    American Board of Psychiatry and Neurology Sleep Medicine

Clinical Trials

Publications & Presentations

PubMed

Other

Press Mentions

  • Updated Guidelines for the Treatment of Restless Leg Syndrome: New Research Prompts a Significant Shift in Recommendations
    Updated Guidelines for the Treatment of Restless Leg Syndrome: New Research Prompts a Significant Shift in RecommendationsDecember 3rd, 2024
  • Guidelines Developed for Treatment of Restless Legs Syndrome
    Guidelines Developed for Treatment of Restless Legs SyndromeDecember 3rd, 2024
  • An RLS Prescription Revolution May Have Begun
    An RLS Prescription Revolution May Have BegunNovember 20th, 2024
  • Join now to see all

Grant Support

  • Eszopiclone To Counteract Adverse Metabolic Consequences Of Primary InsomniaNational Center For Research Resources2007–2008

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: